Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Haaglanden Medical Centre
- Trial code
- NCT05851989
- Record updated
- 16 October 2026
- Original description
The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored.Read full original descriptionShow less
The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored.
Furthermore, cost effectiveness and radiological prognostic factors will be examined.
Inclusion: Confirmed diagnosis of subarachnoid haemorrhage on CT-scan or lumbar puncture (in the presence of a negative CT-scan); Intracranial aneurysm proven within 6 months to be the cause of subarachnoid haemorrhage; Age 18 years or over at presentation; Written informed consent.
Exclusion: Subarachnoid haemorrhage deemed most likely of 'perimesencephalic' origin after consideration of history, clinical examination and radiological findings (including angiographic imaging); Subarachnoid haemorrhage deemed most likely of post-traumatic origin after consideration of history, clinical examination and radiological findings (including angiographic imaging); Diagnosis of intracerebral arteriovenous malformations or dural arteriovenous fistula; No diagnosis of intracranial aneurysm at 6 months after onset of symptoms; Not mastering the Dutch language.